• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物发现中的金属有机化合物:过去、现在和未来。

Organometallic compounds in drug discovery: Past, present and future.

机构信息

Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France.

Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France.

出版信息

Drug Discov Today Technol. 2020 Dec;37:117-124. doi: 10.1016/j.ddtec.2019.06.001. Epub 2019 Jun 27.

DOI:10.1016/j.ddtec.2019.06.001
PMID:34895650
Abstract

In this review, we present an overview of some of the medicinally-relevant organometallic drugs that have been used in the past or that are currently in clinical trials as well as an example of compounds that are currently in the initial stage of drug development. Three main classes of organometallic complexes have been chosen for discussion: antimicrobial organoarsenicals, antimalarial and anticancer ferrocene-containing compounds and anticancer catalytic organometallic complexes. The purpose of this review is to provide readers with a focus on the significant progress that has been made for each of these respective fields of medicine.

摘要

在这篇综述中,我们介绍了一些过去曾用于医学或目前正在临床试验中的药用金属有机药物,以及一些处于药物开发初始阶段的化合物的例子。选择了三类主要的金属有机配合物进行讨论:抗菌有机胂化合物、抗疟和抗癌含二茂铁化合物以及抗癌催化金属有机配合物。本文的目的是为读者提供一个重点,了解这些医学领域各自取得的重要进展。

相似文献

1
Organometallic compounds in drug discovery: Past, present and future.药物发现中的金属有机化合物:过去、现在和未来。
Drug Discov Today Technol. 2020 Dec;37:117-124. doi: 10.1016/j.ddtec.2019.06.001. Epub 2019 Jun 27.
2
Organometallic complexes: new tools for chemotherapy.金属有机配合物:化疗的新工具。
Curr Med Chem. 2010;17(25):2729-45. doi: 10.2174/092986710791859306.
3
Underestimated potential of organometallic rhenium complexes as anticancer agents.有机金属铼配合物作为抗癌剂的潜在价值被低估。
ACS Chem Biol. 2014 Oct 17;9(10):2180-93. doi: 10.1021/cb500528c. Epub 2014 Aug 25.
4
Progress in the Utilisation of Organometallic Compounds in the Development of Cancer Drugs.
Klin Onkol. 2019 Fall;32(Supplementum 3):25-33. doi: 10.14735/amko20193S.
5
Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.基于二茂铁的抗疟疾/抗癌化合物。
Molecules. 2019 Oct 7;24(19):3604. doi: 10.3390/molecules24193604.
6
Design of Ru-arene Complexes for Antitumor Drugs.用于抗肿瘤药物的钌-芳烃配合物的设计
Mini Rev Med Chem. 2018;18(2):184-193. doi: 10.2174/1389557517666170510113453.
7
Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.药用有机金属化学:设计金属芳烃配合物作为抗癌剂。
Chem Asian J. 2008 Nov 13;3(11):1890-9. doi: 10.1002/asia.200800149.
8
Organometallic compounds in cancer therapy: past lessons and future directions.癌症治疗中的有机金属化合物:过去的经验教训与未来方向。
Anticancer Agents Med Chem. 2014;14(9):1199-212. doi: 10.2174/1871520614666140829124925.
9
Highly Potent Antibacterial Organometallic Peptide Conjugates.高效能抗菌金属有机肽缀合物。
Acc Chem Res. 2017 Oct 17;50(10):2510-2518. doi: 10.1021/acs.accounts.7b00282. Epub 2017 Sep 27.
10
Development and future prospects of selective organometallic compounds as anticancer drug candidates exhibiting novel modes of action.选择性有机金属化合物作为具有新型作用模式的抗癌药物候选物的开发和未来前景。
Eur J Med Chem. 2019 Aug 1;175:269-286. doi: 10.1016/j.ejmech.2019.04.062. Epub 2019 May 1.

引用本文的文献

1
Cyclometalated complexes: promising metallodrugs in the battle against cancer.环金属化配合物:抗癌斗争中颇具潜力的金属药物。
RSC Med Chem. 2025 Jul 31. doi: 10.1039/d5md00178a.
2
Synthesis, Structure, Electrochemistry, and In Vitro Anticancer and Anti-Migratory Activities of ()- and ()-2-Substituted-3-Ferrocene-Acrylonitrile Hybrids and Their Derivatives.(±)-2-取代-3-二茂铁基丙烯腈杂化物及其衍生物的合成、结构、电化学性质以及体外抗癌和抗迁移活性
Molecules. 2025 Jul 2;30(13):2835. doi: 10.3390/molecules30132835.
3
X-ray fluorescence microscopy and X-ray absorption spectroscopy reveal the stability of the plecstatin-1 scaffold in biological model systems: comparison of Ru, Os and Ir analogues.
X射线荧光显微镜和X射线吸收光谱揭示了plecstatin-1支架在生物模型系统中的稳定性:钌、锇和铱类似物的比较。
Chem Sci. 2025 May 29. doi: 10.1039/d5sc02925b.
4
Antiproliferative effects, mechanism of action and tumor reduction studies in a lung cancer xenograft mouse model of an organometallic gold(i) alkynyl complex.一种有机金属金(I)炔基配合物在肺癌异种移植小鼠模型中的抗增殖作用、作用机制及肿瘤缩小研究
RSC Med Chem. 2025 Mar 24. doi: 10.1039/d4md00964a.
5
Crystal structure and Hirshfeld surface analysis of ()--{chloro-[(4-ferrocenylphen-yl)imino]-meth-yl}-4-ferrocenylaniline ,-di-methyl-formamide monosolvate.()-氯-[(4-二茂铁基苯基)亚氨基]-甲基}-4-二茂铁基苯胺,N,N-二甲基甲酰胺单溶剂合物的晶体结构和 Hirshfeld 表面分析
Acta Crystallogr E Crystallogr Commun. 2024 Feb 2;80(Pt 3):262-266. doi: 10.1107/S2056989024001002. eCollection 2024 Mar 1.
6
Synthesis and Antiparasitic Activity of New Trithiolato-Bridged Dinuclear Ruthenium(II)-arene-carbohydrate Conjugates.新型三硫代桥联双核钌(II)-芳基-碳水化合物轭合物的合成及抗寄生虫活性。
Molecules. 2023 Jan 16;28(2):902. doi: 10.3390/molecules28020902.
7
New Nucleic Base-Tethered Trithiolato-Bridged Dinuclear Ruthenium(II)-Arene Compounds: Synthesis and Antiparasitic Activity.新型核酸碱基连接的三硫醇桥联双核钌(II)-芳基配合物的合成与抗寄生虫活性。
Molecules. 2022 Nov 24;27(23):8173. doi: 10.3390/molecules27238173.
8
Metal Complexes for Therapeutic Applications.用于治疗应用的金属配合物。
Trends Chem. 2021 Jul;3(7):523-534. doi: 10.1016/j.trechm.2021.03.006. Epub 2021 Apr 14.
9
Interaction of Carrier Protein with Potential Metallic Drug Candidate -Glycoside 'GATPT': Validation by Multi-Spectroscopic and Molecular Docking Approaches.载脂蛋白与潜在金属药物候选物-糖苷“GATPT”的相互作用:多光谱和分子对接方法的验证。
Molecules. 2021 Nov 2;26(21):6641. doi: 10.3390/molecules26216641.
10
Crystal structure and Hirshfeld surface analysis study of ()-1-(4-chloro-phen-yl)--(4-ferrocenylphen-yl)methanimine.()-1-(4-氯苯基)-2-(4-二茂铁基苯基)甲亚胺的晶体结构和 Hirshfeld 表面分析研究
Acta Crystallogr E Crystallogr Commun. 2021 Aug 10;77(Pt 9):875-879. doi: 10.1107/S2056989021008033. eCollection 2021 Sep 1.